Injectable Cushioning Hydrogels for Early Cartilage Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis focus on symptom suppression and fail to prevent or treat initial cartilage damage, which often leads to invasive surgeries, and existing hydrogels lack the necessary mechanical properties and biocompatibility for minimal-invasive treatment.
Innovation Solution
Injectable hydrogels with reversible cross-links that form a cushion between joint surfaces, dissipating stress, maintaining hydrostatic pressure, and promoting cartilage regeneration, using a combination of chemical and physical cross-links.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If injectable hydrogels are designed to provide cushioning and stress dissipation for cartilage protection, then the mechanical properties (elasticity, stress relaxation) are improved, but the device complexity and formulation complexity increase due to the need for reversible cross-links and specific polymer compositions
Solution Approach 1:
The hydrogel formulation combines multiple polymer components (polymer gellants with specific functional groups) and cross-linking agents to create a composite material system. This composite structure provides both the required cushioning mechanical properties through reversible cross-links and maintains relative formulation simplicity by using well-defined polymer chemistry components that can be mixed in specific ratios to achieve the desired balance between protection and biocompatibility.
2Strength
If the hydrogel provides strong mechanical support and cushioning through cross-linking, then the strength and durability are improved, but the biocompatibility and immunological response may worsen due to potential foreign body reactions
Solution Approach 1:
The patent utilizes parameter changes in the polymer composition and cross-linking density to optimize the balance between mechanical strength and biocompatibility. By adjusting the molecular weight, functional group composition, and cross-linking ratio of the polymer components, the hydrogel achieves sufficient mechanical support while maintaining biocompatible properties that minimize immunological foreign body reactions. The reversible cross-links also allow the material to adapt its mechanical properties in response to the biological environment.
3Object-affected harmful factors
If the hydrogel is designed to be biodegradable for temporary protection, then the long-term immunological risk is reduced, but the duration of protective action is limited
Solution Approach 1:
The hydrogel incorporates dynamic reversible cross-links that allow the material to adapt its structure and properties over time. This dynamic characteristic enables the hydrogel to provide effective mechanical protection during the critical early healing phase while gradually degrading as the cartilage regenerates. The reversible cross-links facilitate controlled biodegradation by allowing the polymer network to reorganize and break down into biocompatible byproducts, thus reducing long-term immunological risk while maintaining protective function during the needed timeframe.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogels effectively prevent further cartilage degeneration, reduce pain, and induce matrix deposition by chondrocytes, addressing initial cartilage damage and providing a temporary, biocompatible solution without invasive devices.
Implementation Method 1
comprising polymer gellants that after cross-linking with an aqueous auxiliary composition result in elastic and cushioning hydrogels
Implementation Method 2
comprise reversible cross-links which favor stress relaxation
Implementation Method 3
These cushioning hydrogels can be used in the prevention and treatment of osteoarthritis... dampening this mechanical load can decrease its destructive stimulus
Data Source
Figure 1
AI summary
The invention relates to a kit of parts, consisting of compositions (C1) and (C2) in separate containers, for use in the treatment or prevention of osteoarthritis in a vertebrate, wherein: (a) composition (C1) is a liquid hydrogel formulation comprising a polymer gellant with chemically cross-linkable groups; (b) composition (C2) is an aqueous auxiliary formulation comprising either one or more dissolved cross-linkers Z having two or more reactive groups that can chemically cross-link the polymer gellant by forming covalent bonds; or comprising one or more dissolved compounds Y, selected from the group consisting of oxidant, oxidase, peroxidase and combinations thereof, that initiate or mediate chemical cross-linking of the polymer gellant; wherein said treatment comprises combining compositions (C1) and (C2) to form a liquid hydrogel composition (C3) and administering said liquid hydrogel composition (C3) to the synovial fluid or to the cavity of a synovial joint of the vertebrate, to form a cross-linked hydrogel (C4) in the synovial joint of the vertebrate; or wherein said treatment comprises in a first step administering one of the compositions (C1) or (C2) to the synovial fluid or to the cavity of a synovial joint of the vertebrate and in a second step administering the other of the compositions (C1) or (C2), to form a liquid hydrogel composition (C3) in the synovial joint of the vertebrate that reacts to a cross-linked hydrogel (C4).